BridgeMD
New treatment option for Head and Neck Cancer
Official title Prehabilitation Protocol for Head and Neck Cancer Patients
ClinicalTrials.gov ID: NCT07318220
What this study is testing
- What it's testing
- The purpose of this research is to help researchers understand the barriers, supports, and preferences for prehabilitation. Prehabilitation in this study means head and neck cancer patients will receive nutritional counseling sessions and attend exercise programs before and during radiotherapy/chemoradiotherapy treatment.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80. Healthy volunteers may be eligible.
You may be able to join if
- Aim 2 Implement prehabilitation prescription protocol and evaluate the feasibility and acceptability of the prehabilitation prescription protocol in...
- Age 18 to 80 years old
- Patients with a diagnosis of non-metastatic squamous cell carcinoma originating in the head and neck (oral cavity, oropharynx, hypopharynx, larynx...
- Patients with a plan for curative radiation therapy (RT) / chemoradiation therapy (CRT) at SCCC\ - \ Patients who underwent surgery for the HNC are...
- Clearance for exercise by the medical team.
You likely can't join if
- A patient with a metastatic cancer.
- A patient who cannot complete the baseline assessment and/or start prehabilitation by the initiation of RT/CRT.
- Any contraindication for diet change or exercising as determined by a physician. week for the prior month.
- A patient who is not an English or Spanish speaker.
- History of dementia or major psychiatric disease which would interfere with study.
- History of recent (≤1 yr) stroke, myocardial infarction, or congestive heart failure
See the full eligibility criteria
- Aim 2 Implement prehabilitation prescription protocol and evaluate the feasibility and acceptability of the prehabilitation prescription protocol in a sample of HNC patients.
- Age 18 to 80 years old
- Patients with a diagnosis of non-metastatic squamous cell carcinoma originating in the head and neck (oral cavity, oropharynx, hypopharynx, larynx, and nasopharynx).
- Patients with a plan for curative radiation therapy (RT) / chemoradiation therapy (CRT) at SCCC\ - \ Patients who underwent surgery for the HNC are still eligible.
- Clearance for exercise by the medical team.
- Patients who do not have their first treatment scheduled within 3 weeks at the time of recruitment.
- An English or Spanish speaker. Aim 2
- A patient with a metastatic cancer.
- A patient who cannot complete the baseline assessment and/or start prehabilitation by the initiation of RT/CRT.
- Any contraindication for diet change or exercising as determined by a physician. week for the prior month.
- A patient who is not an English or Spanish speaker.
- History of dementia or major psychiatric disease which would interfere with study.
- History of recent (≤1 yr) stroke, myocardial infarction, or congestive heart failure
- Eastern Cooperative Oncology Group (ECOG) equal to or higher than 2.
The study team makes the final eligibility decision.
Where it's taking place
- Miami, Florida, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Miami, Florida, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.